Skip to main content

Peregrine Pharmaceuticals (NASDAQ:PPHM) Investor Files Lawsuit In Conncetion With Executive Compensation

  • If you purchased shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) you have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

October 22, 2013 (Shareholders Foundation) - An investor who holds shares of Peregrine Pharmaceuticals (NASDAQ:PPHM) filed a lawsuit against directors of Peregrine Pharmaceuticals in connection with allegedly excessive compensation. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:PPHM stockholders by agreeing to exce...



You must register (for free) or login to view the entire case.